Visit our virtual booth and listen to our talk during the Cell & Gene Therapy Bioprocessing & Commercialization virtual event.

Our team

Talk: Next-Generation Transfection Reagent for Large Scale AAV Manufacturing

Transient transfection of suspension cells is the most commonly used production platform for AAV manufacturing.

However, this method shows some limitations in large scale bioreactors: inadequate transfection protocol, reduced transfection efficiency and lower productivity. To address this concern, we present data on the novel transfection reagent showing: i) increased AAV titers, ii) improved transfection protocol for large scale bioreactors and iii) reproducibility of viral titers at different production scale.

Presented by Mathieu Porte, R&D Production  Manager at Polyplus-transfection®

Talk Available on demande on the In Vivo Gene Therapy track for the duration of the virtual event


General information

Registration link for virtual event: click here